Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
YM-155 Hydrochloride: Precision Survivin Inhibitor Workflows
2026-06-29
YM-155 hydrochloride delivers highly selective survivin inhibition, enabling advanced oncology research in apoptosis and tumor regression. This article details best-practice workflows, troubleshooting, and actionable protocol parameters for robust, reproducible results in diverse cancer models.
-
Early Life Adversity Impairs Innate Defense via Oxytocin Pat
2026-06-29
This study uncovers how early life social deprivation disrupts visually evoked innate defensive behaviors in mice by impairing oxytocin signaling in the superior colliculus. The findings identify a direct neural and molecular link between early adversity, oxytocin receptor downregulation, and threat response deficits, providing new insights for translational neurobiology and intervention strategies.
-
Fosinopril Sodium: Mechanistic Precision for Translational C
2026-06-28
This thought-leadership article explores Fosinopril sodium’s unique mechanistic, pharmacokinetic, and workflow advantages as an ACE inhibitor in translational cardiovascular and renal disease models. Integrating biochemical depth, protocol recommendations, and strategic guidance, it positions Fosinopril sodium as a pivotal tool for advancing hypertension and cardio-renal research.
-
Hydroxychloroquine Sulfate: Protocols for Autoimmune Disease
2026-06-27
Hydroxychloroquine Sulfate (SKU B4874) is designed to inhibit autophagy and TLR7/9 signaling in autoimmune disease research, particularly in systemic lupus erythematosus and rheumatoid arthritis models. It is optimized for use in aqueous-based workflows with short-term solution stability and is not suitable for protocols that require solubility in organic solvents or long-term storage.
-
Silybin A in Silymarin: Optimizing Hepatoprotective Assays
2026-06-26
Silybin A, the bioactive powerhouse of Silymarin, is redefining workflows in liver disease and metabolic research with its robust antioxidant and pathway-modulating properties. Discover protocol refinements, troubleshooting tactics, and comparative advantages for maximizing reproducibility and assay success with APExBIO’s high-purity Silybin A.
-
Dacarbazine Workflows: Applied Protocols & Troubleshooting i
2026-06-26
Dacarbazine remains a gold-standard antineoplastic chemotherapy drug for modeling DNA damage and cytotoxicity in cancer research. This comprehensive guide delivers stepwise protocol enhancements, real-world troubleshooting, and insights on leveraging APExBIO's Dacarbazine for robust, reproducible results—especially in malignant melanoma, Hodgkin lymphoma, and sarcoma studies.
-
Indole-3-pyruvic Acid (IPA): Reliable Solutions for Immune a
2026-06-25
This article addresses practical challenges in cell viability and immune modulation assays, emphasizing how Indole-3-pyruvic acid (SKU C8759) delivers reproducible, literature-backed performance. From protocol optimization to vendor reliability, readers gain evidence-based guidance for integrating IPA into advanced research workflows.
-
Prolonging Mouse Corneal Epithelial Proliferation via 6C Med
2026-06-25
An et al. introduce a novel serum-free 6C medium that significantly extends the proliferative activity of mouse corneal epithelial cells (mCECs) in vitro and in vivo. By strategically combining small-molecule pathway modulators—including the ALK5 inhibitor SB 431542—the study advances protocols for generating transplantable epithelial sheets and elucidates mechanisms limiting epithelial-mesenchymal transition (EMT) in regenerative ophthalmology.
-
AO/PI Staining Solution: Precision in Fluorescent Cell Viabi
2026-06-24
AO/PI Staining Solution delivers unmatched accuracy in live/dead cell discrimination by leveraging dual fluorescent DNA dyes. Its optimized workflow enables researchers to confidently quantify cell viability, even in complex disease models like diabetic nephropathy, while avoiding common pitfalls of traditional stains.
-
Peptide Affinity Tags for Imaging Pseudomonas Phages in AMR
2026-06-23
The referenced study introduces a peptide that specifically binds to the Pseudomonas aeruginosa lytic bacteriophage 'Good Vibes,' enabling fluorescent labeling and real-time imaging of phages. This innovation offers a practical method to monitor phage dynamics, addressing a crucial need for non-antibiotic approaches to track and evaluate phage therapy in antimicrobial resistance research.
-
Safe DNA Gel Stain: Sensitive, Safer DNA and RNA Gel Visuali
2026-06-23
Safe DNA Gel Stain transforms DNA and RNA gel staining by combining high sensitivity with a significant reduction in mutagenic risk. By enabling blue-light and UV excitation, it delivers reliable nucleic acid detection and supports enhanced cloning efficiency, all while prioritizing laboratory safety and workflow flexibility.
-
CFTRinh-172: Precision CFTR Inhibition in Epithelial Models
2026-06-22
CFTRinh-172 delivers rapid, highly specific CFTR inhibition, empowering researchers to dissect chloride channel function and model disease-relevant epithelial transport. This article bridges cutting-edge SHC-1/CFTR trafficking insights with practical workflows, troubleshooting, and optimization tips for advanced cystic fibrosis and secretory disorder research.
-
Vancomycin Hydrochloride: Applied Workflows for Resistance A
2026-06-22
Vancomycin hydrochloride is the gold-standard glycopeptide antibacterial agent for dissecting Gram-positive resistance mechanisms and benchmarking susceptibility workflows. This guide distills data-driven protocols, troubleshooting insights, and comparative perspectives, ensuring reliable performance in advanced microbiology and translational models.
-
Filipin III: Polyene Macrolide Antibiotic for Cholesterol De
2026-06-21
Filipin III stands apart as a gold-standard cholesterol probe, offering specificity and fluorescence-based quantitation for membrane research. Recent studies reveal its essential role in mapping cholesterol dysregulation in disease models, empowering scientists to dissect membrane dynamics and pathophysiology with precision.
-
Chemerin in cNTS Elevates Sympathetic Activity via Superoxid
2026-06-20
This study demonstrates that chemerin in the caudal nucleus tractus solitarius (cNTS) increases sympathetic outflow and blood pressure through CMKLR1-mediated NADPH oxidase activation and superoxide production. The findings clarify the signaling mechanisms underlying chemerin’s central cardiovascular effects and distinguish NMDA receptor involvement from non-NMDA glutamatergic pathways.